US2022289744A1PendingUtilityA1
Immunomodulators and immunomodulator conjugates
Est. expiryJan 28, 2036(~9.5 yrs left)· nominal 20-yr term from priority
Inventors:David Ferguson
C07D 471/04A61K 39/39
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides the compound: or a salt thereof, as well as pharmaceutical compositions comprising the compound or a pharmaceutically acceptable salt thereof and methods for treating a pathological condition in an animal with the compound or with a pharmaceutically acceptable salt thereof.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . The compound:
or a salt thereof.
2 . A pharmaceutical composition comprising a compound as described in claim 1 or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable diluent or carrier.
3 . A method for treating a pathological condition in an animal comprising administering a compound as described in claim 1 or a pharmaceutically acceptable salt thereof to the animal.
4 . A method for stimulating an immune response in an animal comprising administering a compound as described in claim 1 or a pharmaceutically acceptable salt thereof to the animal.
5 . A method for treating cancer in an animal comprising administering a compound as described in claim 1 or a pharmaceutically acceptable salt thereof to the animal.Join the waitlist — get patent alerts
Track US2022289744A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.